MicroRNA Profiles in Triple Negative Breast Cancer

NCT04771871 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

University College Hospital, Ibadan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]